NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,443 | -15.4% | 7,597 | +10.5% | 0.01% | 0.0% |
| Q2 2023 | $110,513 | -7.7% | 6,877 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $119,729 | +71.0% | 6,877 | -9.3% | 0.01% | +100.0% |
| Q4 2022 | $70,021 | +7.3% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $65,247 | +14.9% | 7,578 | +8.8% | 0.00% | +50.0% |
| Q2 2022 | $56,781 | -32.9% | 6,967 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $84,649 | -91.7% | 6,967 | -76.8% | 0.00% | -78.6% |
| Q4 2021 | $1,023,498 | -29.3% | 29,997 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $1,447,055 | +4.2% | 29,997 | -2.4% | 0.02% | +5.0% |
| Q2 2021 | $1,388,661 | +0.0% | 30,743 | +6.8% | 0.02% | -4.8% |
| Q1 2021 | $1,388,011 | -13.8% | 28,779 | -3.8% | 0.02% | -12.5% |
| Q4 2020 | $1,610,193 | +45.9% | 29,907 | 0.0% | 0.02% | +26.3% |
| Q3 2020 | $1,103,269 | +12.7% | 29,907 | -5.4% | 0.02% | +11.8% |
| Q2 2020 | $979,247 | +24.0% | 31,609 | +10.5% | 0.02% | 0.0% |
| Q1 2020 | $789,922 | -9.8% | 28,610 | -4.4% | 0.02% | +13.3% |
| Q4 2019 | $875,745 | +49.6% | 29,940 | -2.2% | 0.02% | +50.0% |
| Q3 2019 | $585,321 | -1.1% | 30,613 | +13.5% | 0.01% | 0.0% |
| Q2 2019 | $591,985 | +9.2% | 26,982 | +1.8% | 0.01% | 0.0% |
| Q1 2019 | $542,088 | +114.8% | 26,495 | +32.4% | 0.01% | +100.0% |
| Q4 2018 | $252,377 | -17.9% | 20,014 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $307,215 | -99.9% | 20,014 | +4.6% | 0.01% | +25.0% |
| Q2 2018 | $250,938,000 | +60.7% | 19,141 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $156,190,000 | +91776.5% | 19,141 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $170,000 | -59.2% | 19,141 | -48.9% | 0.00% | -33.3% |
| Q3 2017 | $417,000 | +19.8% | 37,432 | -3.6% | 0.00% | +50.0% |
| Q2 2017 | $348,000 | +13.7% | 38,841 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $306,000 | -10.0% | 38,841 | -2.1% | 0.00% | 0.0% |
| Q4 2016 | $340,000 | +4.3% | 39,694 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $326,000 | +2.5% | 39,694 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $318,000 | +19.5% | 39,514 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $266,000 | -14.5% | 39,514 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $311,000 | +37.6% | 39,514 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $226,000 | +2.7% | 39,514 | -2.9% | 0.00% | 0.0% |
| Q2 2015 | $220,000 | – | 40,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |